<i>SETD2</i> mutations do not contribute to clonal fitness in response to chemotherapy in childhood B cell acute lymphoblastic leukemia-Reference-Cited by-全球学者库

SETD2 mutations do not contribute to clonal fitness in response to chemotherapy in childhood B cell acute lymphoblastic leukemia

Published:2023-10-24 Issue:1 Volume:65 Page:78-90
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Contreras Yametti Gloria P.¹,Robbins Gabriel¹,Chowdhury Ashfiyah¹,Narang Sonali¹,Ostrow Talia H.¹,Kilberg Harrison¹,Greenberg Joshua¹,Kramer Lindsay¹,Raetz Elizabeth¹,Tsirigos Aristotelis²,Evensen Nikki A.¹^ORCID,Carroll William L.¹³

Affiliation:

1. Division of Pediatric Hematology/Oncology, Department of Pediatrics, Perlmutter Cancer Center, NYU Langone Health, New York, NY, USA

2. Departments of Pediatrics and Pathology, Perlmutter Cancer Center, NYU Langone Health, New York, NY, USA

3. Department of Pathology, NYU Langone Health, New York, NY, USA

Funder

National Cancer Institute of Health

Hyundai Hope On Wheels

The Leukemia and Lymphoma Society

Perlmutter Cancer Center Arline and Norman M. Feinberg Pilot Grant for Lymphoid Malignancies

NCI/NIH

Pediatric Cancer Foundation

Sohn Conference Foundation

Hyundai Hope on Wheels

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

https://www.tandfonline.com/doi/pdf/10.1080/10428194.2023.2273752

Reference61 articles.

1. Factors influencing survival after relapse from acute lymphoblastic leukemia: a Children's Oncology Group study

2. Genome-wide copy number profiling reveals molecular evolution from diagnosis to relapse in childhood acute lymphoblastic leukemia

3. Integrated genomic analysis of relapsed childhood acute lymphoblastic leukemia reveals therapeutic strategies

4. Genomic Analysis of the Clonal Origins of Relapsed Acute Lymphoblastic Leukemia

5. CREBBP mutations in relapsed acute lymphoblastic leukaemia